Respiratory Syncytial Virus Infections
"Respiratory Syncytial Virus Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Virus Infections".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Virus Infections".
This graph shows the total number of publications written about "Respiratory Syncytial Virus Infections" by people in Harvard Catalyst Profiles by year, and whether "Respiratory Syncytial Virus Infections" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 0 | 2 | 2 |
1996 | 4 | 0 | 4 |
1998 | 2 | 1 | 3 |
1999 | 3 | 0 | 3 |
2000 | 7 | 4 | 11 |
2001 | 4 | 0 | 4 |
2003 | 2 | 0 | 2 |
2004 | 8 | 0 | 8 |
2005 | 2 | 3 | 5 |
2006 | 4 | 1 | 5 |
2007 | 1 | 0 | 1 |
2008 | 3 | 0 | 3 |
2009 | 3 | 0 | 3 |
2010 | 5 | 0 | 5 |
2011 | 5 | 0 | 5 |
2012 | 4 | 2 | 6 |
2013 | 2 | 1 | 3 |
2014 | 6 | 2 | 8 |
2015 | 7 | 0 | 7 |
2016 | 9 | 2 | 11 |
2017 | 5 | 2 | 7 |
2018 | 10 | 0 | 10 |
2019 | 6 | 3 | 9 |
2020 | 7 | 2 | 9 |
2021 | 16 | 1 | 17 |
2022 | 13 | 1 | 14 |
2023 | 21 | 0 | 21 |
2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Respiratory Syncytial Virus Infections" by people in Profiles.
-
Bacterial small RNAs may mediate immune response differences seen in respiratory syncytial virus versus rhinovirus bronchiolitis. Front Immunol. 2024; 15:1330991.
-
Impact of SARS-CoV-2 Prevention Measures on Non-SARS-CoV-2 Hospital-Onset Respiratory Viral Infections: An Incidence Trend Analysis From 2015-2023. Clin Infect Dis. 2023 Dec 15; 77(12):1696-1699.
-
Implications of Food and Drug Administration Approval of Respiratory Syncytial Virus Prophylactic Medication. Pediatr Rev. 2023 Dec 01; 44(12):723-724.
-
Respiratory Virus-Specific Nasopharyngeal Lipidome Signatures and Severity in Infants With Bronchiolitis: A Prospective Multicenter Study. J Infect Dis. 2023 11 11; 228(10):1410-1420.
-
Risk factors for severe respiratory syncytial virus infection during the first year of life: development and validation of a clinical prediction model. Lancet Digit Health. 2023 11; 5(11):e821-e830.
-
Society for Maternal-Fetal Medicine Statement: Clinical considerations for the prevention of respiratory syncytial virus disease in infants. Am J Obstet Gynecol. 2024 Feb; 230(2):B41-B49.
-
Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine. J Virol. 2023 Nov 30; 97(11):e0077123.
-
Respiratory viral infection and resolution of inflammation: Roles for specialized pro-resolving mediators. Exp Biol Med (Maywood). 2023 10; 248(19):1635-1644.
-
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023 Oct 13; 72(41):1115-1122.
-
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged =60 Years - IVY Network, 20 U.S. States, February 2022-May 2023. MMWR Morb Mortal Wkly Rep. 2023 Oct 06; 72(40):1083-1088.